
### [NCIT:C7764](http://purl.obolibrary.org/obo/NCIT_C7764)
**Label:** Atypical Lymphoproliferative Disorder

**Subclasses:** [NCIT:C131906](http://purl.obolibrary.org/obo/NCIT_C131906) (EBV-Positive Mucocutaneous Ulcer), [NCIT:C115200](http://purl.obolibrary.org/obo/NCIT_C115200) (Localized Angiofollicular Lymphoid Hyperplasia), [NCIT:C3056](http://purl.obolibrary.org/obo/NCIT_C3056) (Angiofollicular Lymphoid Hyperplasia), [NCIT:C27853](http://purl.obolibrary.org/obo/NCIT_C27853) (Angiofollicular Lymphoid Hyperplasia, Hyaline-Vascular Type), [NCIT:C27854](http://purl.obolibrary.org/obo/NCIT_C27854) (Angiofollicular Lymphoid Hyperplasia, Plasma Cell Type), 

**Class expressions from DL-Learner:**

- [UBERON:0002465](http://purl.obolibrary.org/obo/UBERON_0002465) (lymphoid system) 56.25%
- [NCIT:C38439](http://purl.obolibrary.org/obo/NCIT_C38439) (Mature Lymphocyte) 56.25%
- [NCIT:C37165](http://purl.obolibrary.org/obo/NCIT_C37165) (Atypical Lymphocyte) 56.25%
- Thing 52.26%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 34.43%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 25.80%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 25.53%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 25.17%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 25.15%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 25.03%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 24.68%
- [CL:0002087](http://purl.obolibrary.org/obo/CL_0002087) (nongranular leukocyte) 23.16%
- [CL:0000542](http://purl.obolibrary.org/obo/CL_0000542) (lymphocyte) 23.16%
- [CL:0002242](http://purl.obolibrary.org/obo/CL_0002242) (nucleate cell) 23.04%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 22.85%


